Table 2.

Change in HbA_1c percentage and diabetes treatment satisfaction, by group.

Outcome		IV/UCa		UC/IVb		P value
		n	Mean (SD)	n	Mean (SD)
Baseline
	HbA1cc %	59	10.3 (1.4)	60	10.0 (1.4)	.25
	DTSQd	56	29.6 (5.3)	59	28.4 (5.2)	.24
6-month follow-up
	∆ HbA1c % from baseline (ITTe)	56	−1.1 (1.5)	60	−0.8 (1.5)	.29
	∆ HbA1c % from baseline (completer)	47	−1.1 (1.5)	49	−0.7 (1.3)	.14
	DTSQcf	42	+12.9 (5.5)	46	+10.7	.09
12-month follow-up
	∆ HbA1c % from 6-month (ITT)	56	+0.2 (1.7)	60	−0.4 (1.5)	.07
	∆ HbA1c % from 6-month (completer)	41	+0.3 (1.7)	39	−0.4 (1.0)	.03
	DTSQc	40	+11.5 (6.8)	42	+13.4 (5.8)	.15

^aIV/UC: intervention for 6 months before usual care for 6 months.

^bUC/IV: usual care for 6 months before intervention for 6 months.

^cHbA_1c: hemoglobin A_1c.

^dDTSQ: Diabetes Treatment Satisfaction Questionnaire.

^eITT: intent-to-treat.

^fDTSQc: Diabetes Treatment Satisfaction Questionnaire Change.